In 117 people with leprosy-related neuropathic pain, add-on amitriptyline for 9 weeks did not reduce pain intensity (100-mm VAS) more than placebo. Global impression of change was better with amitriptyline; adverse events 81% vs 94%, none serious.
RCTn = 117
Pentiado Júnior et al. Amitriptyline for neuropathic pain in patients with leprosy: a bicenter randomized controlled trial